REVIGO analysis shows that biological processes well known to be under FoxM1 regulation, such as cell cycle, apoptosis, and proliferation, are most affected by CDI-treated MDA-MB-231 cells. The gene discussed is FOXM1; the disease is clostridium difficile infection.